A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.

ABSTRACT:

SUBMITTER: Vanderweil SG 

PROVIDER: S-EPMC5176345 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature